data to be collected from study patients
| Patient factors | Aneurysm factors | Outcomes |
|---|---|---|
| Gender | Connective tissue disorder | Technical outcomes |
| Age | Presenting symptoms of aneurysm | Treatment (BMT/ESG/OSR) |
| Height | Extent of aneurysm | Reoperation for bleeding |
| Weight | Aortic diameter immediately proximal to aneurysm | Access vessel injury |
| Hypertension | Aortic diameter immediately distal to aneurysm | Endoleak |
| Diabetes mellitus | Maximum diameter of thoracic aorta on presentation | Endoleak treatment |
| Smoking history | Aneurysm length | Conversion to open surgery |
| LV function | Proximal neck length | Infection |
| Coronary artery disease | Distal neck length | Fistulae |
| Valvular heart disease | Reintervention | |
| COPD | Aneurysm growth rate | |
| Creatinine | Clinical outcomes | |
| Previous neurovascular injury | Death | |
| Extracardiac arteriopathy | CVA (neuro deficit >48 h) | |
| Logistic Euroscore | Myocardial infarction | |
| Previous cardiac/aortic intervention | Mechanical respiratory support >48 h | |
| Family history of aneurysm | Renal replacement therapy | |
| Living status | Paraplegia | |
| EQ-5D-5L | DVT/PE | |
| EQ-5D-5L | ||
| Cost outcomes | ||
| Operating room time | ||
| Hybrid theatre time | ||
| Prosthesis | ||
| Blood products | ||
| ICU days | ||
| HDU days | ||
| Ward days (preoperative+postoperative) | ||
| Medications | ||
| Investigations in-hospital | ||
| Outpatient visits | ||
| Outpatient investigations | ||
| Treatment of complications | ||
| Primary care visits |
BMT, best medical therapy; COPD, chronic obstructive pulmonary disease; CVA, cerebrovascular accident; DVT, deep vein thrombosis; ESG, endovascular stent grafting; HDU, high-dependency unit; ICU, intensive care unit; LV, left ventricle; OSR, open surgical repair; PE, pulmonary embolism.